Cite
HARVARD Citation
Liu, J. et al. (2022). Olaparib maintenance monotherapy in Chinese patients with platinum‐sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial. Asia-Pacific journal of clinical oncology. 18 (6), pp. 714-722. [Online].